GSK (GSK) – Analyst Comments
-
JPMorgan on GlaxoSmithKline (GSK:LN) (GSK): 'Dr. Sherbonou continues to see the ocular toxicity profile of Blenrep as challenging'
-
Guggenheim Upgrades GlaxoSmithKline (GSK) to Buy, 'Vaccines, HIV, I&I, AND Oncology Set Up Improved 2024+ Growth'
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to GSK Stock Lookup